Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market Size to Exceed $3.33 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market Grown from 2024 to 2025?
The market size for testing chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) has seen rapid expansion in the recent past. There is an expected rise from $1.98 billion in 2024 to $2.2 billion in 2025, witnessing a compound annual growth rate (CAGR) of 11.1%. This significant growth in the preceding era has been due to the rise of antibiotic resistance, the impact of awareness campaigns and education, as well as shifts in policies.
What Growth Rate Is Anticipated for the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market in the Coming Years?
In the forthcoming years, the market size for testing chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) is projected to witness fast-paced growth, reaching $3.33 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.9%. This forecasted growth can be linked to several factors including telehealth services, tailored personalized medicine, the growth of point-of-care testing, and population health management approaches. The future trends shaping this market will be the expansion of swift point-of-care testing, tailored testing strategies, multi-disease testing platforms, and an increased focus on community-based testing and outreach initiatives.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14667&type=smp
Who Are the Leading Companies in the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market?
Major companies operating in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Grifols SA, Hologic Inc., PerkinElmer, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, QIAGEN, Quidel Corporation, DiaSorin, Cepheid, Seegene Inc., Meridian Bioscience Inc., Sekisui Diagnostics, J. Mitra & Co. Pvt. Ltd., Atlas Medical, Hardy Diagnostics, Molbio Diagnostics Pvt. Ltd., NG Biotech
What Are the Key Drivers of the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market?
The escalating rates of sexually transmitted infections (STIs) are projected to boost the expansion of the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market in the future. STIs are diseases that spread through bacteria, viruses, or parasites, resulting from various sexual activities. The surge in STI incidence can be attributed to inadequate comprehensive sexual education, increased instances of sexual activity, social stigma, and related barriers. The CT and NG tests play a crucial role in identifying and dealing with STIs by aiding early detection, facilitating treatment, and preventing contagion. For example, as per the World Health Organization’s data report in July 2023, every day the world encounters over 1 million new STI cases and annually around 374 million fresh cases of 1 of 4 treatable STIs are reported. Consequently, the increasing prevalence of STIs is spurring the growth of the CTNG testing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14667&type=smp
What Are the Key Market Segments in the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Industry?
The chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market covered in this report is segmented –
1) By Test Type: Laboratory, Point Of Care Testing
2) By Product: Assays And Kits, Instruments Or Analyzers
3) By Technology: Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, Immunodiagnostics, Other Technologies
4) By End User: Diagnostic Laboratories, Hospitals And Clinics, Other End Users
Subsegments:
1) By Laboratory: Nucleic Acid Amplification Tests (NAAT), Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence Assay (IFA), Culture Tests, Direct Fluorescent Antibody (DFA) Tests
2) By Point Of Care Testing: Rapid Diagnostic Tests (RDT), Lateral Flow Assays, Immunochromatographic Tests, Self-Testing Kits, Loop-Mediated Isothermal Amplification (LAMP), Microfluidics-Based Tests
What Are the Latest Trends in the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market?
The chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market’s leading players are prioritizing the creation of cutting-edge testing methods, exemplified by the BD COR MX/PX System. This advanced infectious disease molecular diagnostic platform is built with a view to perfectly satisfy the requirements for precise, optimized, and scalable testing techniques to tackle the rising concern of sexually transmitted diseases. As a high-tech laboratory tool, the BD COR MX/PX System is crafted to speedily and effectively scrutinize a large volume of samples for the existence of infectious entities. Becton Dickinson and Company, an American medical device firm, unveiled its innovative, entirely automated infectious disease molecular diagnostics platform, the BD COR MX/PX System, in May 2022. This launch was aimed at simplifying the operational flow in large laboratories conducting numerous infectious disease evaluations, specifically for chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG). The system uses robotics and software algorithms to automate the process from sample intake to results presentation, which can considerably enhance productivity and potentially shorten the waiting period for test outcomes. On top of that, the platform includes automated functions, high-processing capabilities, dual DNA targets, and a modular and scalable structure.
Access The Full Report Here:
What Are the Key Regional Markets in the Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Industry?
North America was the largest region in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market in 2024. The regions covered in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14667
This Report Delivers Insight On:
1. How big is the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market, and how is it changing globally?
2. Who are the major companies in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market, and how are they performing?
3. What are the key opportunities and risks in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market right now?
4. Which products or customer segments are growing the most in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
5. What factors are helping or slowing down the growth of the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
